natgillin/translations-raw huggingface dataset:
Very rare: Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell’s syndrome), increased pigmentary changes of the nails, acute paronychia, furunculosis, telangiectasia.
Vrlo rijetko: Stevens-Johnsonov sindrom, toksična epidermalna nekroliza (Lyellov sindrom), pojačane promjene pigmentacije noktiju, akutna paronihija, furunkuloza, teleangiektazije
Very rare: Stevens-Johnson syndrome/toxic epidermal necrolysis.
Vrlo rijetko: Stevens-Johnsonov sindrom/toksična epidermalna nekroliza.
Very rare: Stevens-Johnson syndrome2, toxic epidermal necrolysis2
Rijetko: pojava recidiva kožnih reakcija izazvanih zračenjem, radijacijski pneumonitis
Very rare: syncope3
Vrlo rijetko: sinkopa3
Very rare: the following may affect up to 1 in 10,000 people
Vrlo rijetke (javljaju se u manje od 1 na 10 000 osoba):
Very rare: Thromboembolism, usually associated with severe OHSS
Vrlo rijetko: tromboembolija, obično povezana s teškim OHSS
Very rare: Thromboembolism, usually associated with severe OHSS
Vrlo rijetko: tromboembolija, obično povezana s teškim OHSS-om
Very rare: Thromboembolism, usually associated with severe OHSS
Vrlo rijetko: Tromboembolija, obično povezana s teškim OHSS.
Very rare: Thromboembolism, usually associated with severe OHSS (see section 4.4)
Vrlo rijetko: Tromboembolija, obično povezana s teškim OHSS-om (vidjeti dio 4.4)
Very rare: Thromboembolism, usually associated with severe OHSS (see section 4.4)
Vrlo rijetko: Tromboembolizam, obično povezana s teškim OHSS-om (vidjeti dio 4.4)
Very rare: Toxic epidermal necrolysis
Vrlo rijetko : toksična epidermalna nekroliza
Very rare: toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme Not known: cutaneous lupus erythematosus, pustular psoriasis or worsening psoriasis
Vrlo rijetko: toksična epidermalna nekroliza, Stevens-Johnsonov sindrom, multiformni eritem Nepoznato: kožni eritemski lupus, pustularna psorijaza ili pogoršanje psorijaze
Very rare: Urticaria
Eritematozni ili makulopapulozni osip Urtikarija
Very rare: Weight decrease
Vrlo rijetko: Smanjenje tjelesne težine
Very rarely (may affect up to 1 in 10,000 people)
Vrlo rijetko (mogu se javiti u do 1 na 10 000 osoba)
Very rarely (may affect up to 1 in 10,000 people) a severe form of allergic reaction has occurred, especially just after an injection.
Vrlo rijetko (mogu se javiti u do 1 na 10 000 osoba) je došlo do teškog oblika alergijske reakcije, pogotovo odmah nakon injekcije.
Very rarely (may affect up to 1 in 10,000 people) a severe form of allergic reaction has occurred, especially just after an injection.
Vrlo rijetko (mogu se javiti u manje od 1 na 10 000 osoba) je došlo do teškog oblika alergijske reakcije, pogotovo odmah nakon injekcije.
Very rarely (may affect up to 1 in 10,000 people) patients taking metformin (one of the active substances of Competact) have experienced a condition called lactic acidosis (excess of lactic acid in your blood), particularly those whose kidneys are not working properly.
Vrlo rijetko (može se javiti u do 1 na 10 000 osoba), bolesnici koji uzimaju metformin (jednu od djelatnih tvari u lijeku Competact) razvili su poremećaj koji se zove laktacidoza (previše mliječne kiseline u krvi), osobito bolesnici sa smanjenom bubrežnom funkcijom.
Very rarely (may affect up to 1 in 10,000 people) patients taking metformin (one of the active substances of Efficib) have experienced a serious condition called lactic acidosis (too much lactic acid in your blood).
Vrlo rijetko (mogu se javiti u do 1 na 10 000 osoba) su bolesnici koji uzimaju metformin (jednu od djelatnih tvari lijeka Efficib) dobili ozbiljno stanje koje se zove laktacidoza (previše mliječne kiseline u krvi).
Very rarely (may affect up to 1 in 10,000 people) patients taking metformin (one of the active substances of Janumet) have experienced a serious condition called lactic acidosis (too much lactic acid in your blood).
Vrlo rijetko (mogu se javiti u do 1 na 10 000 osoba) su bolesnici koji uzimaju metformin (jednu od djelatnih tvari lijeka Janumet) dobili ozbiljno stanje koje se zove laktacidoza (previše mliječne kiseline u krvi).
Very rarely (may affect up to 1 in 10,000 people) patients taking metformin (one of the active substances of Ristfor) have experienced a serious condition called lactic acidosis (too much lactic acid in your blood).
Vrlo rijetko (mogu se javiti u do 1 na 10 000 osoba) su bolesnici koji uzimaju metformin (jednu od djelatnih tvari lijeka Ristfor) dobili ozbiljno stanje koje se zove laktacidoza (previše mliječne kiseline u krvi).
Very rarely (may affect up to 1 in 10,000 people) patients taking metformin (one of the active substances of Velmetia) have experienced a serious condition called lactic acidosis (too much lactic acid in your blood).
Vrlo rijetko (mogu se javiti u do 1 na 10 000 osoba) su bolesnici koji uzimaju metformin (jednu od djelatnih tvari lijeka Velmetia) dobili ozbiljno stanje koje se zove laktacidoza (previše mliječne kiseline u krvi).
Very rarely (may affect up to 1 in 10,000 people) people experienced flu-like symptoms, especially when they just started treatment.
Vrlo rijetko (mogu se javiti u do 1 na 10 000 osoba) se u bolesnika javljaju simptomi nalik gripi, posebno na samom početku liječenja.
Very rarely (may affect up to 1 in 10,000 people), patients have had rising levels of potassium or phosphates in the blood.
Vrlo rijetko (mogu se javiti u do 1 na 10 000 osoba) je bolesnicima porasla razina kalija ili fosfata u krvi.
Very rarely (may affect up to 1 in 10,000 people), patients have had rising levels of potassium or phosphates in the blood.
Vrlo rijetko (mogu se javiti u manje od 1 na 10 000 osoba) je bolesnicima porasla razina kalija ili fosfata u krvi.
Very rarely a clot may form in a vein in another organ such as the eye (retinal vein thrombosis).
Vrlo rijetko, krvni ugrušak može nastati u veni nekog drugog organa, kao što je oko (tromboza retinalne vene).
Very rarely a clot may form in a vein in another organ such as the eye (retinal vein thrombosis).
Vrlo rijetko, krvni ugrušak može se stvoriti u veni nekog drugog organa, kao što je oko (tromboza retinalne vene).
Very rarely patients taking metformin (one of the active substances of Glubrava) have experienced a condition called lactic acidosis (excess of lactic acid in your blood), particularly those whose kidneys are not working properly.
Vrlo rijetko, bolesnici koji uzimaju metformin (jednu od djelatnih tvari u lijeku Glubrava) razvili su poremećaj koji se zove laktacidoza (previše mliječne kiseline u krvi), osobito bolesnici sa smanjenom bubrežnom funkcijom.
Very rarely patients taking metformin (one of the active substances of Glubrava) have experienced this condition, particularly those whose kidneys are not working properly.
To stanje nastaje u vrlo rijetkim slučajevima u bolesnika koji uzimaju metformin (jednu od djelatnih tvari u lijeku Glubrava), osobito oni čiji bubrezi ne funkcioniraju ispravno.
Very rarely patients taking metformin (one of the active substances of Jentadueto) have experienced a serious condition called lactic acidosis (too much lactic acid in your blood).
Vrlo su rijetko bolesnici, koji su uzimali metformin (jedna od djelatnih tvari Jentadueta), iskusili ozbiljno stanje pod nazivom laktacidoza (previše mliječne kiseline u krvi).
Very rarely reported side effects:
Vrlo rijetko prijavljene nuspojave:
Very rarely severe and painful reactions have occurred, particularly when more cream has been used than recommended.
Vrlo rijetke nuspojave su ozbiljne i bolne reakcije, osobito u slučajevima primjene veće količine kreme od preporučene.
Very rarely, as with other macrocyclic lactones, reversible neurological signs, including seizures, have been observed after use of the veterinary medicinal product in both dogs and cats.
U vrlo rijetkim okolnostima, kao i kod drugih makrocikličkih laktona, nakon upotrebe veterinarsko – medicinskog proizvoda uočeni su reverzibilni neurološki simptomi i u mačaka i u pasa.
Very rarely, as with other macrocyclic lactones, reversible neurological signs, including seizures, have been observed after use of the veterinary medicinal product in both dogs and cats.
Vrlo rijetko, kao i kod drugih makrocikličkih laktona, nakon upotrebe veterinarsko – medicinskog proizvoda uočeni su reverzibilni neurološki simptomi i u pasa i u mačaka.
Very rarely, medicines of this type cause a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness.
Vrlo rijetko lijekovi ovog tipa uzrokuju kombinaciju vrućice, ubrzanog disanja, znojenja, ukočenosti mišića te omamljenosti ili pospanosti.
Very rarely, medicines of this type cause a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness.
Vrlo rijetko, lijekovi ovog tipa uzrokuju kombinaciju vrućice, ubrzanog disanja, znojenja, ukočenosti mišića te omamljenosti ili pospanosti.
Very rarely, medicines of this type may cause unusual movements mainly of the face or tongue or a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness.
Vrlo rijetko, lijekovi iz ove skupine mogu prouzročiti neuobičajene pokrete (uglavnom lica ili jezika) ili kombinaciju vrućice, ubrzanog disanja, znojenja, mišićne ukočenosti te omamljenosti ili pospanosti.
Very rarely:
vrlo rijetko: nepoznato:
Very rarely: Thromboembolic reactions such as myocardial infarction, stroke, pulmonary embolism, deep vein thromboses.
Vrlo rijetko: Tromboembolijske reakcije kao što su infarkt miokarda, moždani udar, plućna embolija, duboke venske tromboze.
Very slow pulse, heart attack
jako usporeni puls, srčani udar
Very small dog
Vrlo mali pas
Very small dogs (1.2 to 5 kg)
Jako mali psi (1,2 to 5 kg)
Very stressful events, concomitant treatment with gestagens and corticosteroids or other concomitant diseases (e.g. infectious or inflammatory or endocrine diseases), might influence insulin effectiveness and therefore the insulin dose may need to be adjusted.
Vrlo stresni događaji, istovremeno liječenje gestagenima i kortikosteroidima ili druge popratne bolesti (npr. infekcijske ili upalne ili endokrine bolesti), mogu utjecati na djelotvornost inzulina te bi stoga trebalo prilagoditi dozu inzulina.
very thick and / or obvious AK
vrlo debele i/ili očite aktiničke keratoze
Very-low-density lipoprotein cholesterol (VLDL-C) (mg/dL)
Kolesterol - lipoproteini vrlo niske gustoće (VLDL kolesterol) (mg/dl)
vesicles
mjehurići
vesiculobullous rash, pustular rash, maculopapular rash, rash, pruritus, urticaria, skin discolouration (increased pigmentation)1
vezikulobulozni osip, pustulozni osip, makulopapulozni osip, svrbež, pruritus, urtikarija, promjena boje kože (pojačana pigmentacija)1
vesiculobullous rash, pustular rash, maculopapular rash, rash, pruritus, urticaria, skin discolouration (increased pigmentation)1,2
vezikulobulozni osip, pustulozni osip, makulopapularni osip, drugi osip, pruritus, urtikarija, promjena boje kože (pojačana pigmentacija)1,2
vesiculobullous rash, pustular rash, maculopapular rash, rash, pruritus, urticaria, skin discolouration (increased pigmentation)2
vezikulobulozni osip, pustulozni osip, makulopapularni osip, svrbež, urtikarija, promjena boje kože (pojačana pigmentacija)2
Vessel inflammation which may result in very rare cases in temporary kidney problems.
Upala krvnih žila koja se u vrlo rijetkim slučajevima može očitovati privremenim poteškoćama s bubrezima.
Vessel puncture site discharge
iscjedak na mjestu punkcije žile
Vessel puncture site haematoma
hematom na mjestu punkcije žile
Vessel puncture site haematoma b
hematom na mjestu punkcije žile b
Vessel puncture site haematoma Puncture site haemorrhage
hematom na mjestu uboda u krvnu žilu, krvarenje na mjestu uboda
Vessels: flushing (sudden reddening of the face and/or neck), haematoma (a bruise, a black and blue mark), hypotension (low blood pressure)
Žile: crvenilo (naglo crvenilo lica i/ili vrata), hematom (modrice, crni i plavi tragovi), hipotenzija (nizak krvni tlak)
Vestibular disorder
vestibularni poremećaj
Vetem SpA - Lungomare Pirandello, 8 - 92014 Porto Empedocle (AG) - Italy
Lungomare Pirandello, 8 92014 Porto Empedocle (AG) Italy
Veterinary medicinal product not subject to prescription
Veterinarsko-medicinski proizvod se izdaje bez veterinarskog recepta.
Veterinary medicinal product subject to prescription
Veterinarsko – medicinski proizvod na recept.
Veterinary medicinal product subject to prescription
Veterinarsko-medicinski proizvod se izdaje na veterinarski recept.
Veterinary medicinal product subject to prescription
VMP se izdaje na veterinarski recept.
Veterinary medicinal product subject to prescription.
Izdaje se na veterinarski recept
Veterinary medicinal product subject to prescription.
Može se izdavati samo na veterinarski recept.
Veterinary medicinal product subject to prescription.
Veterinarsko medicinski proizvod izdaje se na veterinarski recept
Veterinary medicinal product subject to prescription.
Veterinarsko medicinski proizvod se izdaje na recept.
Veterinary medicinal product subject to prescription.
Veterinarsko-medicinski proizvod izdaje se samo na recept.
Veterinary medicinal product subject to prescription.
Veterinarsko-medicinski proizvod može se izdavati samo na recept.
Veterinary medicinal product subject to prescription.
Veterinarsko-medicinski proizvod se izdaje na veterinarski recept
Veterinary medicinal product subject to prescription.
VMP se izdaje samo na veterinarski recept.
VFEND 200 mg film-coated tablets Voriconazole
VFEND 200 mg filmom obložene tablete vorikonazol
VFEND 200 mg powder for solution for infusion Voriconazole
VFEND 200 mg prašak za otopinu za infuziju vorikonazol
VFEND 40 mg/ml powder for oral suspension Voriconazole
VFEND 40 mg/ml prašak za oralnu suspenziju vorikonazol
VFEND 50 mg film-coated tablets VFEND 200 mg film-coated tablets
VFEND 50 mg filmom obložene tablete VFEND 200 mg filmom obložene tablete
VFEND 50 mg film-coated tablets Voriconazole
VFEND 50 mg filmom obložene tablete vorikonazol
VFEND discontinuation and use of alternative antifungal agents should be considered.
Treba razmotriti prekid primjene lijeka VFEND i primjenu alternativnih antimikotika.
VFEND film-coated tablets are to be taken at least one hour before, or one hour following, a meal.
VFEND filmom obložene tablete moraju se uzimati najmanje jedan sat prije ili jedan sat nakon obroka.
VFEND is presented in single use glass vials as a powder for solution for infusion.
VFEND je dostupan u obliku praška za otopinu za infuziju u staklenoj bočici za jednokratnu uporabu.
VFEND must not be diluted with 4.2% Sodium Bicarbonate Infusion.
VFEND se ne smije razrjeđivati s otopinom natrijevog bikarbonata 4,2% za infuziju.
VFEND must not be used during pregnancy, unless indicated by your doctor.
VFEND se ne smije uzimati tijekom trudnoće osim ako Vaš liječnik nije tako odlučio.
VFEND oral suspension is to be taken at least one hour before, or two hours following, a meal.
VFEND oralna suspenzija se mora uzimati najmanje jedan sat prije ili dva sata nakon obroka.
VFEND powder and solvent for solution for infusion is available in a box containing:
VFEND prašak i otapalo za otopinu za infuziju dostupni su u kutiji koja sadrži:
VFEND powder and solvent for solution for infusion is presented as an administration kit containing:
VFEND prašak i otapalo za otopinu za infuziju isporučuje se u kompletu za primjenu lijeka koji sadrži:
VFEND powder and solvent for solution for infusion will be reconstituted and diluted to the correct concentration by your hospital pharmacist or nurse. (Please refer to the end of this leaflet for further information)
VFEND prašak i otapalo za otopinu za infuziju će pripremiti i razrijediti do točne koncentracije bolnički ljekarnik ili medicinska sestra. (Dodatne informacije navedene su na kraju ove Upute o lijeku).
VFEND powder for solution for infusion in single use glass vial.
VFEND prašak za otopinu za infuziju u staklenoj bočici za jednokratnu uporabu
VFEND powder for solution for infusion needs to first be reconstituted with either 19 ml of Water for Injections or 19 ml of 9 mg/ml (0.9%) Sodium Chloride for Infusion to obtain an extractable volume of 20 ml of clear concentrate containing 10 mg/ml voriconazole.
VFEND prašak za otopinu za infuziju se najprije mora rekonstituirati ili s 19 ml vode za injekcije ili s 19 ml otopine natrijevog klorida 0,9% (9 mg/ml) za infuziju kako bi se dobio iskoristivi volumen od 20 ml bistrog koncentrata koji sadrži 10 mg/ml vorikonazola.
VFEND powder for solution for infusion will be reconstituted and diluted to the correct concentration by your hospital pharmacist or nurse. (Please refer to the end of this leaflet for further information)
VFEND prašak za otopinu za infuziju će bolnički ljekarnik ili medicinska sestra pripremiti i razrijediti do točne koncentracije. (Dodatne informacije navedene su na kraju ove Upute o lijeku).
VFEND should be discontinued if premalignant skin lesions or squamous cell carcinoma are identified.
VFEND treba ukinuti ako se uoče predmaligne lezije kože ili karcinom skvamoznih stanica.
VFEND should not be given to children younger than 2 years of age.
VFEND se ne smije davati djeci mlađoj od 2 godine.
VFEND solvent for solution for infusion in an overwrapped, sterile, single use, polypropylene infusion bag.
VFEND otapalo za otopinu za infuziju u omotanoj, sterilnoj polipropilenskoj infuzijskoj vrećici za jednokratnu uporabu
Vfend voriconazole
Vfend vorikonazol
VFEND, is a broad-spectrum, triazole antifungal agent and is indicated in adults and children aged 2 years and above as follows:
VFEND je antimikotik širokog spektra iz skupine triazola i namjenjen je za primjenu u odraslih i djece u dobi od 2 ili više godina u sljedećim indikacijama:
Via del Commercio – Zona Industriale 63100 Marino del Tronto (Ascoli Piceno) Italy
Via del Commercio – Zona Industriale 63100 Marino del Tronto (Ascoli Piceno) Italija
Via Ettore Bugatti 15 20142 Milano
Via Ettore Bugatti 15 I-20142 Milano
Via Fiorentina 1, 53100 Siena, Italy
Via Fiorentina 1, 53100 Siena, Italija
Via Fiorentina, 1 Siena, Italy.
Via Fiorentina, 1 Siena, Italija.
Via Fiorentina, 1 – 53100 Siena Italy
Via Fiorentina, 1 – 53100 Siena Italija
Via Franco Gorgone Z.I. 95100 Catania (CT) Italy
Via Franco Gorgone Z.I. 95100 Catania (CT) Italija
Via Franco Gorgone Zona Industriale 95100 Catania, Italy
Via Franco Gorgone Zona Industriale 95100 Catania, Italija
Via Galileo Galilei, 19 20867 Caponago (MB) Italy adienne@adienne.com
Via Galileo Galilei, 19 20867 Caponago (MB) Italija adienne@adienne.com
Via Galileo Galilei, 19 20867 Caponago (MB) Italy Tel: +39-02 40700445 adienne@adienne.com
Via Galileo Galilei, 19 20867 Caponago (MB) Italija Tel: +39-02 40700445 adienne@adienne.com
Via its binding to a specific cytoplasmic immunophilin (FKBP12), tacrolimus inhibits calcium- dependent signal transduction pathways in T cells, thereby preventing the transcription and synthesis of IL-2, IL-3, IL-4, IL-5 and other cytokines such as GM-CSF, TNF-α and IFN-γ.
Vezanjem za poseban citoplazmatski imunofilin (FKBP12) takrolimus inhibira puteve prijenosa signala u T stanicama koji ovise o kalciju i tako sprječava transkripciju i sintezu IL-2, IL-3, IL-4, IL-5 i drugih citokina poput GM-CSF, TNF-α i IFN-γ.
Via Lillo del Duca 10 20091 Bresso (MI) - Italy
Via Lillo del Duca 10 20091 Bresso (MI) - Italija
Via Lillo del Duca 10 20091 Bresso (MI) - Italy Tel: +39 02 665241
Via Lillo del Duca 10 20091 Bresso (MI) - Italija tel: +39 02 665241
Via Martin Luther King 13 20060 Pessano Con Bornago ITALY
Via Martin Luther King 13 20060 Pessano Con Bornago Italija
Via Olgettina 58
MolMed SpA Via Olgettina 58‌
Via Palermo 26/A 43122 Parma ITALY
Via Palermo 26/A 43122 Parma Italija
Via Piero Maroncelli 40
Via Piero Maroncelli40
Via Provinciale Schito 131 IT-80058 Torre Annunziata Italy
Via Provinciale Schito 131 IT-80058 Torre Annunziata Italija
Via Ribes 5, Biondustry Park Colleretto Giacosa - 10010 (TO) Italy
Via Ribes 5, Biondustry Park Colleretto Giacosa - 10010 (TO) Italija
VIAGRA 100 mg film-coated tablets EU/1/98/077/010-012 EU/1/98/077/015
VIAGRA 100 mg filmom obložene tablete EU/1/98/077/010-012
VIAGRA 100 mg tablets
VIAGRA 100 mg tablete
VIAGRA 25 mg film-coated tablets EU/1/98/077/002-004 EU/1/98/077/013
VIAGRA 25 mg filmom obložene tablete EU/1/98/077/002-004
VIAGRA 25 mg film-coated tablets VIAGRA 50 mg film-coated tablets VIAGRA 100 mg film-coated tablets
VIAGRA 25 mg filmom obložene tablete VIAGRA 50 mg filmom obložene tablete VIAGRA 100 mg filmom obložene tablete
VIAGRA 25 mg tablets
VIAGRA 25 mg tablete
VIAGRA 50 mg film-coated tablets EU/1/98/077/006-008 EU/1/98/077/014
VIAGRA 50 mg filmom obložene tablete EU/1/98/077/006-008
VIAGRA 50 mg tablets
VIAGRA 50 mg tablete
VIAGRA contains lactose
VIAGRA sadrži laktozu.
VIAGRA film-coated tablets are blue, with a rounded-diamond shape.
VIAGRA filmom obložene tablete su plave boje i imaju oblik romba sa zaobljenim rubovima.
VIAGRA is not indicated for individuals below 18 years of age.
VIAGRA nije indicirana za primjenu u osoba mlađih od 18 godina.
VIAGRA orodispersible tablets are blue, diamond shape, marked “V50” on one side.
VIAGRA raspadljive tablete za usta su plave boje, imaju oblik romba i oznaku „V50“ na jednoj strani.
VIAGRA should not be given to individuals under the age of 18.
VIAGRA se ne smije davati osobama mlađim od 18 godina.
VIAL
BOČICA
Vial (1 dose lyophilisate)
Bočica (1 doza liofilizata)
Vial (1 ml solvent)
Bočica (1 ml otapala)
Vial (100 ml / 250 ml)
Bočica (100 ml / 250 ml)
Vial (100 ml, 250 ml)
Bočica (100 ml, 250 ml)
Vial (20 ml / 50 ml)
Bočica (20 ml / 50 ml)
Vial (20 ml, 50 ml)
Bočica(20 ml, 50 ml)
Vial (50 ml)
Bočica (50 ml)
Vial (500 ml)
Bočica (500 ml)
Vial (amber glass)
Bočica (smeđe staklo)
Vial (Cycloolefinic polymer)
1x 10e6 PFU/ml
Vial (Cycloolefinic polymer)
Bočica (Cikloolefinski polimer)
vial (glass)
(staklena)
vial (glass)
(staklena) bočica
vial (glass)
1 bočica
vial (glass)
10 bočica
vial (glass)
25 bočica
Vial (glass)
Ampulom (staklenom)
Vial (glass)
Bocica (staklena)
vial (glass)
Bočic (staklenim)
vial (glass)
bočica
Vial (glass)
Bočica (stakla)
vial (glass)
bočica (staklena) bočica
vial (glass)
bočica (staklena) bočica (staklena)
Vial (glass)
bočica (staklenih)
Vial (glass)
Bočica (staklo) Bočica (staklo)
vial (glass)
bočica(staklo)
Vial (glass)
bočical (staklena)
Vial (glass)
Bočice (staklo)
Vial (glass)
Bočicu (Staklena)
Vial (glass)
Bočicu (staklenu)
vial (glass)
EU/1/06/358/005
vial (glass)
EU/1/06/358/007
vial (glass)
EU/1/96/020/001
vial (glass)
pakiranje bočica (staklo)
vial (glass)
Staklena bočica
Vial (glass)
Staklenih bočica
Vial (glass)
staklenoj bočica
Vial (glass) + infusion bag
Bočica (staklena) + vrećica za infuziju
vial (glass) cartridge (glass) cartridge (glass) cartridge (glass) cartridge (glass) cartridge (glass) cartridge (glass)
bočica (staklo) uložak (staklo) uložak (staklo) uložak (staklo)
Vial (glass) closed by a
butilne gume
vial (glass) closed by a grey
bočica (staklo) zatvorena
vial (glass) vial (glass)
bočica (staklena) bočica (staklena)
Vial (glass); syringe (plastic)
bočica (staklena); štrcaljka (plastična)
vial (glass); vial (glass)
EU/1/13/840/002
Vial (HDPE)
Bočica (HDPE)
Vial (PET)
Bočica (PET)
Vial (PET)
Bočice ( PET )
Vial (PET)
Bočice ( PET)
vial (plastic)
bočica
vial (plastic)
bočica (plastična)
vial (plastic)
bočica (plastični)
Vial (polyethylene terephthalate [PET])
Bočica (polietilen tereftalat
vial (powder) vial adaptors
1 bočica (prašak)
Vial (PP)
Bočica (PP)
Vial (PP)
Bočica(PP)
Vial (type 1 glass) closed with a disc (bromobutyl/polyisoprene rubber) and a protective tamper-proof plastic cap containing 10 ml of solution.
Bočica (staklo tipa 1) zatvorena pločicom (brombutilna/poliizoprenska guma) i zaštitnim plastičnim zatvaračem s evidencijom otvaranja sadrži 10 ml otopine.
Vial (type 1 glass) closed with a disc (bromobutyl/polyisoprene rubber) and a protective tamper-proof plastic cap containing 10 ml of suspension.
Bočica (staklo tipa 1) zatvorena pločicom (brombutilna/poliizoprenska guma) i zaštitnim plastičnim zatvaračem s evidencijom otvaranja sadrži 10 ml suspenzije.
Vial (type I glass)
Bočica (staklo tip I)
Vial (type I glass)
Staklene bočice tipa I
Vial (Type I glass) with a stopper (butyl rubber) containing 14 ml of solution.
Bočica (staklo tipa I) sa čepom (butilna guma) koja sadrži 14 ml otopine.